The vaccine is designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above. It will be used to support preventive vaccination in countries most ...

The new vaccine – known during its development ... individuals aged 18 years and older at risk of infection from the Ebola virus. “This is an important step towards relieving the burden ...

If the influenza virus infecting cattle workers starts a pandemic, help in the form of a vaccine is months away ...

Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...

The head of a vaccine nonprofit says Rwanda’s speedy outbreak response underscores the role small organisations can play in ...

reported on the development of a preventive vaccine against Ebola, based on adenoviral vectors. In the Ebola virus, envelope glycoproteins (GP) mediate entry into the target cells by facilitating ...

Key ebola virus companies such as Auro Vaccines, INOVIO Pharmaceuticals, RedHill Biopharma Ltd., Emergent BioSolutions, Arisan Therapeutics, TFF Pharmaceuticals, China Immunotech, and others are ...

The Marburg virus belongs to the filovirus family, whose best-known representative is the Ebola virus ... the WHO's prequalification of four vaccines for deployment in the field in the event ...

A cousin to the Ebola virus, Marburg is one of the deadliest ... There are currently no licensed vaccines or treatments for Marburg, but several vaccines are in early-stage clinical trials.